Trip report

A trip report, also known as a psychedelic experience report, is a written account of a subjective psychedelic experience by a person who has taken a psychedelic or other hallucinogenic drug. They are often published on online websites like Erowid, Bluelight, Lycaeum, Drugs Forum, and Reddit, among others, with Erowid's Experience Vaults containing thousands of trip reports.

Among the most famous trip reports are those of chemist Albert Hofmann when he discovered LSD, including Bicycle Day (April 19, 1943) and his initial accidental lower-dose exposure a few days earlier on April 16, 1943. Writer Aldous Huxley's The Doors of Perception (1954) is a book-length trip report about his first experience with mescaline that was administered to him by psychiatrist Humphrey Osmond. Chemist Alexander Shulgin's books PiHKAL (1991) and TiHKAL (1997) contain short trip reports for hundreds of psychedelic drugs.

In the 2020s, researchers have started to analyze trip reports as part of scientific research into the effects of psychedelics. As an example, the pharmaceutical company Mindstate Design Labs processed 70,000 online trip reports with artificial intelligence (AI) and selected 5-MeO-MiPT as a candidate with unique subjective effects for development as a potential pharmaceutical medication.

See also

References

  1. ↑ Bååth, Jonas; Nordgren, Johan (27 October 2022). "Trip Reports". Routledge Handbook of Intoxicants and Intoxication. London: Routledge. pp. 328–341. doi:10.4324/9780429058141-26. ISBN 978-0-429-05814-1. Retrieved 26 April 2025.
  2. 1 2 3 Miceli McMillan, Riccardo; Reynolds, Jack; Fernandez, Anthony (25 November 2024). "The phenomenology of psychedelic temporality: current knowledge, open questions, and clinical applications". Philosophical Psychology: 1–28. doi:10.1080/09515089.2024.2433522. ISSN 0951-5089. Retrieved 26 April 2025.
  3. 1 2 3 Tagliazucchi E (2022). "Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs". Front Pharmacol. 13 812227. doi:10.3389/fphar.2022.812227. PMC 8980225. PMID 35392561.
  4. ↑ Bogenschutz MP (2000). "Drug information libraries on the Internet". J Psychoactive Drugs. 32 (3): 249–258. doi:10.1080/02791072.2000.10400447. PMID 11061675.
  5. 1 2 Luke, David (2022). "Anomalous Psychedelic Experiences: At the Neurochemical Juncture of the Humanistic and Parapsychological". Journal of Humanistic Psychology. 62 (2): 257–297. doi:10.1177/0022167820917767. ISSN 0022-1678.
  6. ↑ Mosurinjohn S, Roseman L, Girn M (2023). "Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique". Front Psychiatry. 14 1077311. doi:10.3389/fpsyt.2023.1077311. PMC 10171200. PMID 37181886.
  7. ↑ Olive, M. Foster (2008). "History of LSD". LSD. Infobase Publishing. pp. 21–33. ISBN 978-0-7910-9709-0. Retrieved 26 April 2025.
  8. ↑ Albert Hofmann (15 August 1994). "History of the Discovery of LSD". In Ladewig, D.; Pletscher, A. (eds.). Fifty Years of LSD: Current Status and Perspectives of Hallucinogens. CRC Press. ISBN 978-1-85070-569-7. Retrieved 26 April 2025.
  9. ↑ Hofmann, Albert (1980). LSD, My Problem Child. Translated by Jonathan Ott. McGraw-Hill. ISBN 978-0-07-029325-0. OCLC 6251390. OL 4100124M.
  10. ↑ Alexander T. Shulgin; Ann Shulgin (1991). PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. ISBN 978-0-9630096-0-9. OCLC 25627628.
  11. ↑ Alexander T. Shulgin; Ann Shulgin (1997). TiHKAL: The Continuation (1st ed.). Berkeley, CA: Transform Press. ISBN 978-0-9630096-9-2. OCLC 38503252.
  12. ↑ Walker, Scott R.; Pullella, Glenn A.; Piggott, Matthew J.; Duggan, Peter J. (5 July 2023). "Introduction to the chemistry and pharmacology of psychedelic drugs". Australian Journal of Chemistry. 76 (5): 236–257. doi:10.1071/CH23050. ISSN 0004-9425. Retrieved 26 April 2025.
  13. ↑ Sumnall HR, Evans-Brown M, McVeigh J (2011). "Social, policy, and public health perspectives on new psychoactive substances". Drug Test Anal. 3 (7–8): 515–523. doi:10.1002/dta.310. PMID 21744515.
  14. ↑ Ballentine G, Friedman SF, Bzdok D (March 2022). "Trips and neurotransmitters: Discovering principled patterns across 6850 hallucinogenic experiences". Sci Adv. 8 (11) eabl6989. Bibcode:2022SciA....8L6989B. doi:10.1126/sciadv.abl6989. PMC 8926331. PMID 35294242.
  15. 1 2 Meissen, Andrew (20 September 2024). "Mindstate Uses AI to Design "Next-Gen" Psychedelics Combined With 5-MeO-MiPT". Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness. Retrieved 10 November 2024.
  16. ↑ Bayer, Max (13 March 2024). "After crunching 70k 'trip reports', Mindstate looks to test first AI-derived psychedelic on humans". Fierce Biotech. Retrieved 10 November 2024.
  17. ↑ Microdose NewsDesk (10 September 2024). "Mindstate Design Labs AI-Designed Trial Gets FDA Approval". Microdose. Retrieved 10 November 2024.